drugset / Trial / NCT00317408

Combination Chemotherapy Followed By Stem Cell Transplant in Treating Young Patients With Progressive or Relapsed Anaplastic Large Cell Lymphoma

NCT00317408

Non-randomizedTreatment

Summary

RATIONALE: Giving combination chemotherapy and total-body irradiation before a peripheral stem cell transplant that uses the patient's or a donor's stem cells, helps stop both the growth of cancer cells and the patient's immune system from rejecting the stem cells. When the stem cells are infused into the patient they may help the patient's bone marrow make stem cells, red blood cells, white blood cells, and platelets. Giving combination chemotherapy and total-body irradiation followed by a stem cell transplant may be an effective treatment for anaplastic large cell lymphoma. PURPOSE: This clinical trial is studying how well combination chemotherapy followed by stem cell transplant works in treating young patients with progressive or relapsed anaplastic large cell lymphoma.

Timeline

Start
2004-04
Primary completion
2014-02
Completion

Drugs

EvaluationDrugModalityDoseRoute
Subject Busulfan Small molecule Oral
Subject Carboplatin Small molecule Intravenous
Subject Cytarabine Small molecule Intrathecal
Subject Dexamethasone Small molecule Oral
Subject Etoposide Small molecule Intravenous
Subject Idarubicin Small molecule Intravenous
Subject Ifosfamide Small molecule Intravenous
Subject Lomustine Small molecule Oral
Subject Melphalan Small molecule Intravenous
Subject Methotrexate Small molecule Intrathecal
Subject Mitoxantrone Small molecule Intravenous
Subject Prednisolone Other / unclassified Intrathecal
Subject Thiotepa Other / unclassified Intravenous
Subject Vinblastine Small molecule Intravenous
Subject Vindesine Small molecule Intravenous
Subject carmustine Small molecule Intravenous
Background ANTILYMPHOCYTE IMMUNOGLOBULIN (HORSE) Protein / enzyme biologic Intravenous
Background Cyclosporine Peptide Intravenous
Background Leucovorin Small molecule Intravenous

Indications